Asston Pharmaceuticals
Asston Pharmaceuticals Share Price Chart
Asston Pharmaceuticals last traded at ₹94.75 (2026-10-13). Over the past month the stock moved -11.4%, three months the stock moved +35.4%, year the stock moved -0.3%. Its closing range over 52 weeks is ₹68.18 – ₹124.95, with the latest close 24.2% below the high.
Closing prices up to 2026-10-13.
About Asston Pharmaceuticals
Incorporated in 2019, Asston Pharmaceuticals Ltd is in the business of manufacturing pharmaceutical products.[1]
Business Overview:[1] APL offers pharmaceutical products in the form of Tablet, Capsules, Syrup, Sachet and Injection (LVP and SVP). The company has WHO GMP approved manufacturing units for manufacturing the entire products range and also has a tie up with a NABL Accredited Laboratory.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 10.05 | -2.80 | -27.86 | 0.48 | 0.56 |
| Sep 2025 | 15.42 | 2.23 | 14.46 | 0.03 | 0.04 |
| Mar 2025 | 9.07 | 3.18 | 35.06 | 1.95 | 3.11 |
| Sep 2024 | 15.97 | 2.26 | 14.15 | 1.90 | 24.24 |
Annual Financials
In the latest year (Mar 2026), Asston Pharmaceuticals reported sales of ₹25.47 crore (+1.7%) and net profit of ₹3.87 crore (+0.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 25.47 | -0.57 | -2.24 | 3.87 | 4.55 |
| Mar 2025 | 25.04 | 5.44 | 21.73 | 3.85 | 6.14 |
| Mar 2024 | 16.03 | 3.82 | 23.83 | 2.43 | 31.00 |
| Mar 2023 | 6.54 | 1.52 | 23.24 | 1.06 | 15.14 |
| Mar 2022 | 9.60 | -0.36 | -3.75 | 0.11 | 1.57 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -31.9% | +145.1% | +56.2% | +1.7% |
| Operating profit growth | – | +151.3% | +42.4% | -110.5% |
| Net profit growth | +863.6% | +129.2% | +58.4% | +0.5% |
| EPS growth | +864.3% | +104.8% | -80.2% | -25.9% |
| OPM % | 23.2% | 23.8% | 21.7% | -2.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Asston Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Asston Pharmaceuticals allots 24.10 lakh equity shares - business-standard.com
-
Asston Pharmaceuticals appoints new auditors, re-appoints managing director - scanx.trade
Frequently Asked Questions
What is the share price of Asston Pharmaceuticals today?
Asston Pharmaceuticals shares were last quoted at ₹94.75 (+0.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Asston Pharmaceuticals?
Asston Pharmaceuticals has a price-to-earnings (P/E) ratio of 162.30 and a price-to-book (P/B) ratio of 2.17. The industry P/E is 52.82.
What is the 52-week high and low of Asston Pharmaceuticals?
The 52-week high of Asston Pharmaceuticals is ₹126.10 and the 52-week low is ₹60.00.
What is the market cap of Asston Pharmaceuticals?
The market capitalisation of Asston Pharmaceuticals is about ₹84.27 crore.
Is Asston Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Asston Pharmaceuticals has a 3-year ROE of 26.00%, 3-year profit growth of 54.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Asston Pharmaceuticals?
Promoters hold about 50.66% of Asston Pharmaceuticals.
Which sector does Asston Pharmaceuticals belong to?
Asston Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.